http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110317235-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G83-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N55-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-045 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G83-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N55-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-80 |
filingDate | 2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110317235-B |
titleOfInvention | Preparation method and application of heteronuclear polymer containing bromobipyridine ligand |
abstract | The invention discloses a 2, 2-bipyridyl ligand copper-nickel heteronuclear polymer and a preparation method and application thereof, the structural formula is as follows, the preparation method comprises the following steps: dissolving 1mmol of oxamide mononuclear copper ligand in 10-20ml of methanol, dissolving 1mmol of nickel salt in 5-10ml of methanol, adding the dissolved nickel salt into a methanol solution of the mononuclear copper ligand, reacting at 60 ℃ for 1 hour, then adding a methanol solution dissolved with 2mmol of 2, 2-bipyridyl ligand into the mixed solution of the ligand, refluxing at 60 ℃ for 5 hours, filtering, and slowly volatilizing the filtrate for 1 week to obtain blue blocky crystals. Namely the copper-nickel heteronuclear polymer containing the 2, 2-bipyridyl ligand, wherein the nickel salt is as follows: nickel perchlorate, nickel chloride, nickel bromide, nickel sulfate, nickel acetate, nickel sulfamate and the like. Compared with the platinum anticancer drugs commonly used at present, the compound of the invention has the characteristics of high anticancer activity, low cost, simple preparation method and the like. Meanwhile, the synthesized compound is found out for the first time in the textThe toxic and killing activity of Aedes albopictus is measured, and a new way is provided for developing insecticidal medicaments with related applications. |
priorityDate | 2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.